Abstract

Background: Candida peritonitis (CP) is generally considered to be a severe disease, but its impact on outcome in critically ill patients remains unknown. Hypothesis: The predictive factors of mortality due to CP can be determined by study of a population of patients with CP. Design: A retrospective review of a prospective surgical intensive care unit (ICU) database of patients (January 1, 1994, through December 31, 2000). Setting: University hospital in Paris, France. Patients: Eighty-three patients with generalized CP. Main Outcome Measures: Demographic and microbiologic data and outcome were collected, and nonsurvivors were compared with survivors. Results: Overall ICU mortality due to CP was 43 (52%) of 83 patients. In a stepwise multivariate logistic regression, the following 4 variables were independently associated with mortality: APACHE II (Acute Physiology and Chronic Health Evaluation II) score on admission of at least 17 (odds ratio [OR], 28.4; 95% confidence interval [CI], 5.7-142.5; P<.001), respiratory failure on admission (OR, 10.6; 95% CI, 2.2-51.2; P=.00.3), upper gastrointestinal tract site of peritonitis (OR, 7.7; 95% CI, 1.7-34.7; P=.007), and results of direct examination of peritoneal fluid that were positive for Candida (OR, 4.7; 95% Cl, 1.2-19.7; P=.002). Conclusions: These results confirm the severity of CP in ICU patients and emphasize the prognostic value of direct examination of peritoneal fluid for Candida in this context.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.